The Temozolomide–Doxorubicin paradox in Glioblastoma in vitro–in silico preclinical drug-screening by Mariam-Eleni Oraiopoulou, Eleftheria Tzamali, Stylianos E. Psycharakis, Georgios Tzedakis, Takis Makatounakis, Katina Manolitsi, Elias Drakos, Antonis F. Vakis, Giannis Zacharakis, Joseph Papamatheakis, Vangelis Sakkalis

Get full text